Senseonics Eversense 365 Shows Strong One-Year CGM Results
BARCELONA, Spain, March 14, 2026 New real-world evidence presented at the 19th International Conference on Advanced Technologies & Treatments...
ADC AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
BARCELONA, Spain, March 14, 2026 New real-world evidence presented at the 19th International Conference on Advanced Technologies & Treatments...
